The nation of Zimbabwe has declined a significant US health deal valued at $367m (£272m) spanning five years over Washington's request for confidential biological samples.
This move came to light after a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
An official representative has since clarified that the US was seeking health data for scientific study and commercial purposes while refused to share the resulting advantages from any future vaccines.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged further negotiations to reach a deal suitable to all parties so the country's vital HIV programme can be sustained.
Broader Implications
This development comes after a comparable situation in neighbouring Kenya, where a court halted a related deal with the US after legal challenges were filed about the security of citizens' medical information.
Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
The agency had managed assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was seeking government-to-government deals to boost transparency and accountability.
Based on reports, 16 African countries have so far signed similar health pacts, constituting over $18.3bn in new funding.
Details of the Rejected Deal
This assistance for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership might have yielded extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," Mangwana explained.
"Put simply, our country would supply the basic resources for scientific discovery with no assurance that the final treatments would be available to our citizens if a future pandemic arise."
Sovereignty and International Frameworks
He also noted that the American exit from the global health body and its pursuit of one-on-one deals were disrupting structures already established through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with potential pandemics.
"This mechanism is designed to ensure that when a country contributes its data, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to ongoing discussions with our US partners on how future co-operation might be designed in a manner that honours the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but suggested that negotiations should continue considering a large portion of the country's Aids initiatives were funded by international support.
"In cases where specific concerns arise, such as those involving data governance or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," it said.
The situation highlights the ongoing tensions between receiving much-needed foreign assistance and protecting national sovereignty in an ever more interconnected world.